COMPLETED

Speech Perception in Bimodal Hearing

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The protocol has two aims; Aim 1 involves two experiments and Aim 2 involves three experiments. Under Aim 1, the investigator will identify that the frequency and time ranges of consonants produce consonant enhancement (i.e., "target frequency range" and "target time range", respectively), and that the frequency and time ranges of consonants cause consonant confusions (i.e., "conflicting frequency range" and "conflicting time range", respectively). Aim 2 tests the effects of the frequency and time ranges, identified through Aim 1 on consonant recognition with each of the four signal processing conditions: no signal processing (i.e., control condition), the target frequency and time ranges intensified alone, the conflicting frequency and time ranges suppressed alone, and both target range intensification and conflicting range suppression.

Official Title

Speech Perception Enhancement Using Novel Signal Processing in Bimodal Hearing

Quick Facts

Study Start:2021-10-25
Study Completion:2025-07-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:COMPLETED

Study ID

NCT05599165

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 74 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * be age from 18-74 years old,
  2. * be native speakers of American English,
  3. * be post-lingually deafened in both ears,
  4. * be healthy enough to manipulate a computer mouse and read information on a computer monitor, and
  5. * have at least 1-year of bimodal use prior to initiation of study participation to account for continuous improvement.
  1. Pregnancy or breastfeeding
  2. Severe psychiatric disorders
  3. Active substance abuse
  4. Unstable medical conditions
  5. Inability to comply with study requirements

Contacts and Locations

Principal Investigator

Yang-Soo Yoon, PhD
PRINCIPAL_INVESTIGATOR
Baylor University

Study Locations (Sites)

Baylor University
Waco, Texas, 76798
United States

Collaborators and Investigators

Sponsor: Baylor University

  • Yang-Soo Yoon, PhD, PRINCIPAL_INVESTIGATOR, Baylor University

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2021-10-25
Study Completion Date2025-07-31

Study Record Updates

Study Start Date2021-10-25
Study Completion Date2025-07-31

Terms related to this study

Additional Relevant MeSH Terms

  • Hearing Loss, Sensorineural